This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
It has been 18 years since the corticosteroids were introduced into clinical use. Since that time, we have learned a great deal about these compounds.
Although all the steroid compounds are of interest to biological scientists, the antiinflammatory steroids are of particular interest to the ophthalmologist because of their great potency in suppressing inflammation and preserving ocular function. Recently these compounds have aroused even greater interest as we learn of such undesirable side effects as glaucoma and cataract production.
The purpose of this issue of the International Ophthalmology Clinics is to summarize present knowledge concerning the effects of corticosteroids on the eye. It will be invaluable to every ophthalmologist. The 12 authors have dealt with the basic pharmacology and physiology of these compounds and their application to clinical situations. There is a good presentation on the response of ocular pressure to steroids.
A negligible criticism is the evident duplication
Wirostko E. Corticosteroids and the Eye. Arch Ophthalmol. 1968;80(1):153. doi:10.1001/archopht.1968.00980050155035
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: